Published Date: 26 Apr 2023
The dreaded hay fever signs, including itchy eyes, sneezing, and a stuffy nose, have arrived for many people with the arrival of spring. Up to 42% of people experience hay fever, making it a widespread condition. Immune system overreaction is the cause of it.
Read Full NewsThe FDA is requiring new labeling across all GLP-1 receptor agonists to warn of a potential increased risk of a rare, vision-threatening optic nerve condition.
David Leehey, MD, says about half of the 2376 enrolled veterans were taking an SGLT2 inhibitor at baseline.
1.
Brain MRI Surveillance Alone May Be Enough in SCLC
2.
Cancer After Weight Loss; How Older Adults Use the Healthcare System.
3.
iPSC-based vaccines: A new hope for preventing and treating colorectal cancer
4.
All-Oral Treatment Combo for AML Earns FDA Nod
5.
Trial Questions Role of Dual Immunotherapy in First-Line NSCLC
1.
Molecular Interaction Maps in Refractory Blood Disease: Mechanistic Insights and Clinical Applications
2.
Guidance for Monitoring Iron Overload
3.
The Transformative Power of Genomics in the Diagnosis and Management of Rare Cancers
4.
Hepatocellular Carcinoma: Progress in Detection, Pathogenesis, and Treatment
5.
Ferroptosis in Cancer Therapy: Mechanisms, Clinical Implications, and Emerging Therapeutic Strategies
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Understanding Anemia and Its Common Causes
2.
Recognizing Symptoms of Vitamin B12 Deficiency
3.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part I
4.
How Multidisciplinary Teams Support Modern Cancer Care
5.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation